Associated Papers
NGS-based targeted gene mutational profiles in Korean patients with pancreatic cancer.
Jung K et al.
Scientific Reports, 2022
36463295 (PubMed )
Supplement: 41598_2022_24732_MOESM1_ESM.xlsx › S4._Overall_mutation_profile
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Palafox M et al.
Nature Communications, 2022
36071033 (PubMed )
Supplement: 41467_2022_32828_MOESM4_ESM.xlsx › Fig_2A_and_Table_S4
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies.
Hatchwell E et al.
Frontiers in Neurology, 2022
36588876 (PubMed )
Supplement: Data_Sheet_1.pdf
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy.
Eis PS et al.
Frontiers in Neurology, 2020
32256442 (PubMed )
Supplement: Data_Sheet_2.pdf
Influence of BRCA1 Germline Mutations in the Somatic Mutational Burden of Triple-Negative Breast Cancer.
Ferreira EN et al.
Translational Oncology, 2019
31419696 (PubMed )
Supplement: mmc1.xlsx › Table_S2
Select a paper to view details